药物对比
Eptinezumab vs Galcanezumab
Eptinezumab（Vyepti）与 Galcanezumab（Emgality）：用于偏头痛预防的CGRP单克隆抗体。Eptinezumab 每3个月静脉注射一次，Galcanezumab 皮下注射每月一次/每3个月一次。疗效相似，给药方案不同。
此页面暂无可用的对比维度。
临床背景
Patients with migraine who are considering CGRP monoclonal antibody preventive treatments.
结论
Both Eptinezumab and Galcanezumab are effective options for migraine prevention, with selection based on dosing preferences and individual factors.
全部药物对比